November 5, 2021
November 5, 2021 – A new dosage form of Dyanavel XR® (amphetamine) has received U.S. FDA approval to treat attention deficit hyperactivity disorder (ADHD) in patients who are at
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Assistance
November 3, 2021
November 3, 2021 – The Advisory Committee on Immunization Practices (ACIP) for the U.S. Centers for Disease Control and Prevention (CDC) now recommends hepatitis B
November 1, 2021
November 1, 2021 – ANI Pharmaceuticals has announced U.S. FDA approval of the company’s Purified CortrophinTM Gel (repository corticotropin injection). The product is indicated to treat
October 29, 2021
October 29, 2021 – Comirnaty® (COVID-19 vaccine, mRNA – Pfizer/BioNTech) has received emergency use
authorization (EUA) to prevent COVID-19 in children 5-11 years
October 29, 2021
October 29, 2021 – The U.S. FDA has approved Scemblix® (asciminib) to treat adults diagnosed with Philadelphia chromosome–positive chronic myeloid leukemia
October 29, 2021
October 29, 2021 – VuityTM (pilocarpine HCI ophthalmic solution) 1.25% has been approved to treat presbyopia. It is the first and only eye drop to receive U.S. FDA approval
October 27, 2021
October 27, 2021 – The U.S. FDA has expanded the indication for cutaquig® [immune globulin subcutaneous (human)-hipp] 16.5% solution to include
October 25, 2021
October 25, 2021 – XipereTM (triamcinolone acetonide injectable suspension) has been approved by the U.S. FDA for suprachoroidal use to treat macular edema